Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_assertion type Assertion NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_head.
- NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_assertion description "[Our results show that CD38 is a novel pharmacological target to treat metabolic diseases via NAD(+)-dependent pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_provenance.
- NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_assertion evidence source_evidence_literature NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_provenance.
- NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_assertion SIO_000772 23172919 NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_provenance.
- NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_assertion wasDerivedFrom befree-2016 NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_provenance.
- NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_assertion wasGeneratedBy ECO_0000203 NP1030332.RAH-TCpBwJZyuavVRf_G-FAgBSn-e-V75tqfqHC8j_wdk130_provenance.